Literature DB >> 21465664

The atypical 16p11.2 deletion: a not so atypical microdeletion syndrome?

Daniela Q C M Barge-Schaapveld1, Saskia M Maas, Abeltje Polstra, Lia C Knegt, Raoul C M Hennekam.   

Abstract

One of the recently recognized microdeletion syndromes is the 16p11.2 deletion syndrome (593 kb; ∼29.5 Mb to ∼30.1 Mb), associated with developmental delay, autism spectrum disorder, epilepsy, and obesity. Less frequently reported is a smaller 220 kb deletion, adjacent and distal to this 16p11.2 deletion, which has been referred to as the atypical 16p11.2 deletion (220 kb; ∼28.74 Mb to ∼28.95 Mb). We describe three patients with this deletion and update the manifestations in two sibs who have been described as possibly new entity in this Journal in 1997 [Bakker and Hennekam (1997); Am J Med Genet 70:312-314] and were recently found to have the "atypical 16p11.2 deletion" as well. Patients show a developmental delay, behavioral problems, and unusual facial morphology (prominent forehead, downslanted, and narrow palpebral fissures), and some are obese. We suggest that this "atypical" deletion may turn out to become a microdeletion syndrome that will be recognizable in the future, or at least to show a phenotype that is recognizable in retrospect. As it may no longer be so "atypical," we suggest renaming the entity "distal 16p11.2 deletion," to distinguish it from the common proximal 16p11.2 deletion.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21465664     DOI: 10.1002/ajmg.a.33991

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  22 in total

1.  16p11.2-p12.2 duplication syndrome; a genomic condition differentiated from euchromatic variation of 16p11.2.

Authors:  John C K Barber; Victoria Hall; Viv K Maloney; Shuwen Huang; Angharad M Roberts; Angela F Brady; Nicki Foulds; Beverley Bewes; Marianne Volleth; Thomas Liehr; Karl Mehnert; Mark Bateman; Helen White
Journal:  Eur J Hum Genet       Date:  2012-07-25       Impact factor: 4.246

2.  Transcriptional consequences of 16p11.2 deletion and duplication in mouse cortex and multiplex autism families.

Authors:  Ian Blumenthal; Ashok Ragavendran; Serkan Erdin; Lambertus Klei; Aarathi Sugathan; Jolene R Guide; Poornima Manavalan; Julian Q Zhou; Vanessa C Wheeler; Joshua Z Levin; Carl Ernst; Kathryn Roeder; Bernie Devlin; James F Gusella; Michael E Talkowski
Journal:  Am J Hum Genet       Date:  2014-06-05       Impact factor: 11.025

3.  Autism multiplex family with 16p11.2p12.2 microduplication syndrome in monozygotic twins and distal 16p11.2 deletion in their brother.

Authors:  Anne-Claude Tabet; Marion Pilorge; Richard Delorme; Frédérique Amsellem; Jean-Marc Pinard; Marion Leboyer; Alain Verloes; Brigitte Benzacken; Catalina Betancur
Journal:  Eur J Hum Genet       Date:  2012-01-11       Impact factor: 4.246

4.  The juvenile Batten disease protein, CLN3, and its role in regulating anterograde and retrograde post-Golgi trafficking.

Authors:  Susan L Cotman; John F Staropoli
Journal:  Clin Lipidol       Date:  2012-02

5.  A common 16p11.2 inversion underlies the joint susceptibility to asthma and obesity.

Authors:  Juan R González; Alejandro Cáceres; Tonu Esko; Ivon Cuscó; Marta Puig; Mikel Esnaola; Judith Reina; Valerie Siroux; Emmanuelle Bouzigon; Rachel Nadif; Eva Reinmaa; Lili Milani; Mariona Bustamante; Deborah Jarvis; Josep M Antó; Jordi Sunyer; Florence Demenais; Manolis Kogevinas; Andres Metspalu; Mario Cáceres; Luis A Pérez-Jurado
Journal:  Am J Hum Genet       Date:  2014-02-20       Impact factor: 11.025

6.  Implication of a rare deletion at distal 16p11.2 in schizophrenia.

Authors:  Saurav Guha; Elliott Rees; Ariel Darvasi; Dobril Ivanov; Masashi Ikeda; Sarah E Bergen; Patrik K Magnusson; Paul Cormican; Derek Morris; Michael Gill; Sven Cichon; Jeffrey A Rosenfeld; Annette Lee; Peter K Gregersen; John M Kane; Anil K Malhotra; Marcella Rietschel; Markus M Nöthen; Franziska Degenhardt; Lutz Priebe; René Breuer; Jana Strohmaier; Douglas M Ruderfer; Jennifer L Moran; Kimberly D Chambert; Alan R Sanders; Jianxin Shi; Kenneth Kendler; Brien Riley; Tony O'Neill; Dermot Walsh; Dheeraj Malhotra; Aiden Corvin; Shaun Purcell; Pamela Sklar; Nakao Iwata; Christina M Hultman; Patrick F Sullivan; Jonathan Sebat; Shane McCarthy; Pablo V Gejman; Douglas F Levinson; Michael J Owen; Michael C O'Donovan; Todd Lencz; George Kirov
Journal:  JAMA Psychiatry       Date:  2013-03       Impact factor: 21.596

7.  An unusual clinical severity of 16p11.2 deletion syndrome caused by unmasked recessive mutation of CLN3.

Authors:  Céline Pebrel-Richard; Anne Debost-Legrand; Eléonore Eymard-Pierre; Victoria Greze; Stéphan Kemeny; Mathilde Gay-Bellile; Laetitia Gouas; Andreï Tchirkov; Philippe Vago; Carole Goumy; Christine Francannet
Journal:  Eur J Hum Genet       Date:  2013-07-17       Impact factor: 4.246

8.  The Immune Signaling Adaptor LAT Contributes to the Neuroanatomical Phenotype of 16p11.2 BP2-BP3 CNVs.

Authors:  Maria Nicla Loviglio; Thomas Arbogast; Aia Elise Jønch; Stephan C Collins; Konstantin Popadin; Camille S Bonnet; Giuliana Giannuzzi; Anne M Maillard; Sébastien Jacquemont; Binnaz Yalcin; Nicholas Katsanis; Christelle Golzio; Alexandre Reymond
Journal:  Am J Hum Genet       Date:  2017-09-28       Impact factor: 11.025

Review 9.  Recent Advances in the Genetics of Schizophrenia.

Authors:  Dimitrios Avramopoulos
Journal:  Mol Neuropsychiatry       Date:  2018-05-30

10.  Genetic basis of hyperlysinemia.

Authors:  Sander M Houten; Heleen Te Brinke; Simone Denis; Jos Pn Ruiter; Alida C Knegt; Johannis Bc de Klerk; Persephone Augoustides-Savvopoulou; Johannes Häberle; Matthias R Baumgartner; Turgay Coşkun; Johannes Zschocke; Jörn Oliver Sass; Bwee Tien Poll-The; Ronald Ja Wanders; Marinus Duran
Journal:  Orphanet J Rare Dis       Date:  2013-04-09       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.